Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial
Roche Pharmaceuticals' CEO told investors she was "serious" about the goal of becoming a top 3 obesity player.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Pharmaceuticals
since
auto-detected in 5 stories
72 days ago
6 months ago
23andMe to delist from Nasdaq, deregister with SEC
Regeneron Pharmaceuticals said earlier this month that it will acquire "substantially all" of 23andMe's assets for $256 million.
Regeneron Pharmaceuticals to buy 23andMe and its data for $256 million
Regeneron is acquiring "substantially all" of 23andMe's assets for $256 million following a bankruptcy auction.
7 months ago
How Takeda's CEO transformed the company into a global pharma powerhouse
found
Takeda Pharmaceuticals, Japan's largest drugmaker, has undergone a sweeping transformation under CEO Christophe Weber, emerging as one of the world's leading pharmaceutical companies.
How Takeda's CEO transformed the company into a global pharma powerhouse
found
a story from CNBC ⚠️ › World News
Takeda Pharmaceuticals, Japan's largest drugmaker, has undergone a sweeping transformation under CEO Christophe Weber, emerging as one of the world's leading pharmaceutical companies.
page 1 of 1